Anaerobic culture of diabetic foot infections: Organisms and antimicrobial susceptibilities

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 11, 2008, Pages 936-939

  Ng, Lily S Y ^a   Lee, Ling Kwang ^a   Yeow, Susan C S ^a   Thean, Yen Tan ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Anaerobe; Antibiotic resistance; Bacterial

Indexed keywords

CLINDAMYCIN; IMIPENEM; METRONIDAZOLE;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DIABETIC FOOT; HUMAN; NONHUMAN; PEPTOSTREPTOCOCCUS;

EID: 57649201111     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bhalla V, Fong CW, Chew SK, Satku K. Changes in the levels of major cardiovascular risk factors in the multi-ethnic population in Singapore after 12 years of a national non-communicable disease intervention programme. Singapore Med J 2006;47:841-50.
2. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997;25:1318-26.
3. Lipsky BA. Medical treatment of diabetic foot infections. Clin Infect Dis 2004;39 Suppl 2:S104-14.
4. Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 2001;45:1238-43.
5. Teng LJ, Hsueh PR, Tsai JC, Liaw SJ, Ho SW, Luh KT. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob Agents Chemother 2002;46:2908-13.
6. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Goldstein EJ, Finegold SM, et al. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. Clin Infect Dis 2002;35Suppl1:S126-34.
7. Brazier JS, Stubbs SL, Duerden BI. Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned? J Antimicrob Chemother 1999;44:580-1.
8. Jousimies-Somer HE, Summanen PH, Wexler H, Finegold SM, Gharbia SE, Shah HN. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-positive bacteria. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. 8th ed. Washington, DC: ASM Press, 2003:857-901.
9. Baron EJ, Citron DM. Anaerobic identification flowchart using minimal laboratory resources. Clin Infect Dis 1997;25 Suppl 2:S143-6.
10. Harmsen D, Singer C, Rothgänger J, Tønjum T, de Hoog GS, Shah H, et al. Diagnostics of neisseriaceae and moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J Clin Microbiol 2001;39:936-42.
11. th ed. Wayne, PA, USA: NCCLS, 2004.
12. Sapico FL, Canawati HN, Witte JL, Montgomerie JZ, Wagner FW Jr, Bessman AN. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol 1980;12:413-20.
13. Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2006;42:57-62.
14. Chen SC, Gottlieb T, Palmer JM, Morris G, Gilbert GL. Antimicrobial susceptibility of anaerobic bacteria in Australia. J Antimicrob Chemother 1992;30:811-20.
15. Wybo I, Piérard D, Verschraegen I, Reynders M, Vandoorslaer K, Claeys G, et al. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 2007;59:132-9.
16. Falagas ME, Siakavellas E. Bacteroides, Prevotella, and Porphyromonas species: a review of antibiotic resistance and therapeutic options. Int J Antimicrob Agents 2000;15:1-9.